Clinical Trial

Differences in Extracellular Vesicles From Adipose Tissue of Individuals With Obesity.

Study acronym: EVO
Recruiting
View on ClinicalTrials.gov →
Summary
Our society is characterized by a strong increase in the prevalence of obesity, which often causes the development of cardiovascular and metabolic diseases such as type 2 diabetes. The way(s) obesity is responsible for these diseases, is still insufficiently understood. This study therefore examines the content of human fat tissue storage location- and cell type-specific extracellular vesicles (EVs) in lean and obese individuals, and the possible connection with sex, insulin sensitivity, and the blood-brain barrier.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-05-30.
Trial Details
NCT Number NCT06444646
Lead Sponsor Hasselt University
Collaborators: Research Foundation Flanders, Ziekenhuis Oost-Limburg
Conditions Obesity
Enrollment 150 participants
Start Date 2023-02-20
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-09-15